Vertiv Holdings Co (VRT) stock
VRTNYSEElectronic Components, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 28, 2026Score 19/3018% above fair value
$232.50−13.42 (-5.46%)
Close on Oct 30, 2026Market cap $89.51BP/E 52.6Yield –
Earnings
Vertiv's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 10, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$4.31B
+61.2% on a year earlier
adjusted diluted EPS, Q3 FY2026
$2.21
$1.24 a year earlier
Latest guidance
Issued
Oct 28, 2026 · 14 items
Quarterly results
Revenue and earnings per share from each of Vertiv's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 10, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026before the open | $4.31B | +61.2% | $1.95 | $2.21 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 29, 2026before the open | $3.27B | +24.1% | $1.27 | $1.52 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 22, 2026before the open | $2.65B | +30.2% | $0.99 | $1.17 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 11, 2026before the open | $2.88B | +22.8% | $1.14 | $1.36 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 22, 2025before the open | $2.68B | +29.0% | $1.02 | $1.24 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 30, 2025before the open | $2.64B | +35.1% | $0.83 | $0.95 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 23, 2025before the open | $2.04B | +24.2% | $0.42 | $0.64 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 12, 2025before the open | $2.35B | +25.8% | $0.38 | $0.99 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 23, 2024before the open | $2.07B | +19.0% | $0.46 | $0.76 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 24, 2024before the open | $1.95B | +12.6% | $0.46 | $0.67 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 24, 2024before the open | $1.64B | +7.8% | -$0.02 | $0.43 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 21, 2024before the open | $1.87B | +12.7% | $0.60 | $0.56 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 25, 2023before the open | $1.74B | +17.7% | $0.24 | $0.52 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023before the open | $1.73B | +23.9% | $0.22 | $0.46 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 26, 2023before the open | $1.52B | +31.6% | $0.12 | $0.24 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 22, 2023before the open | $1.66B | +17.3% | $0.07 | $0.28 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 26, 2022before the open | $1.48B | +20.5% | $0.06 | $0.23 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 3, 2022before the open | $1.40B | – | $0.05 | $0.10 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 27, 2022before the open | $1.16B | – | -$0.23 | -$0.08 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 23, 2022before the open | $1.41B | – | $0.06 | $0.04 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 27, 2021before the open | $1.23B | – | $0.15 | $0.20 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 28, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 23, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 24, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 4, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Vertiv's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net salesGAAP | Q4 FY2026 | $4.31B – $4.51B | – | New | Oct 28, 2026 |
| Organic net sales growthnon-GAAP | Q4 FY2026 | +49% – +51% | – | New | Oct 28, 2026 |
| Adjusted operating profitnon-GAAP | Q4 FY2026 | $1.12B – $1.16B | – | New | Oct 28, 2026 |
| Adjusted operating marginnon-GAAP | Q4 FY2026 | 25.3% – 26.3% | – | New | Oct 28, 2026 |
| diluted EPSGAAP | Q4 FY2026 | $2.08 | – | New | Oct 28, 2026 |
| Adjusted diluted EPSnon-GAAP | Q4 FY2026 | $2.22 – $2.28 | – | New | Oct 28, 2026 |
| Net salesGAAP | FY2026 | $14.45B – $14.85B | – | New | Oct 28, 2026 |
| Net sales | FY2026 | $13.80B – $14.20B | $13.50B – $14.00B | Raised | Jul 29, 2026 |
| Net salesnon-GAAP | FY2026 | $13.25B – $13.75B | – | New | Feb 11, 2026 |
| Organic net sales growthnon-GAAP | FY2026 | +37% – +39% | – | New | Oct 28, 2026 |
| Organic net sales growthnon-GAAP | FY2026 | +30% – +32% | +27% – +29% | Raised | Jul 29, 2026 |
| Adjusted operating profitnon-GAAP | FY2026 | $3.48B – $3.56B | – | New | Oct 28, 2026 |
| Adjusted operating profitnon-GAAP | FY2026 | $3.29B – $3.37B | $3.14B – $3.26B | Raised | Jul 29, 2026 |
| Operating profit (loss)GAAP | FY2026 | $2.77B | – | New | Feb 11, 2026 |
| Adjusted operating marginnon-GAAP | FY2026 | 23.5% – 24.5% | – | New | Oct 28, 2026 |
| Adjusted operating marginnon-GAAP | FY2026 | 23.3% – 24.3% | 22.8% – 23.8% | Raised | Jul 29, 2026 |
| diluted EPSGAAP | FY2026 | $6.29 | – | New | Oct 28, 2026 |
| diluted EPSGAAP | FY2026 | $5.82 – $5.92 | $5.60 – $5.70 | Raised | Jul 29, 2026 |
| Adjusted diluted EPSnon-GAAP | FY2026 | $7.10 – $7.20 | – | New | Oct 28, 2026 |
| Adjusted diluted EPSnon-GAAP | FY2026 | $6.65 – $6.75 | $6.30 – $6.40 | Raised | Jul 29, 2026 |
| Adjusted free cash flownon-GAAP | FY2026 | $2.60B – $2.80B | – | New | Oct 28, 2026 |
| Adjusted free cash flownon-GAAP | FY2026 | $2.40B – $2.60B | $2.10B – $2.30B | Raised | Jul 29, 2026 |
| Capital expenditures | FY2026 | 4% | – | New | Oct 28, 2026 |
| Capital expenditures | FY2026 | 4% | – | New | Jul 29, 2026 |
| Adjusted diluted EPS growthnon-GAAP | FY2026 | +58% – +61% | +50% – +52% | Raised | Jul 29, 2026 |
| Organic net sales growthnon-GAAP | FY2026 | +29% – +31% | – | Lowered | Apr 22, 2026 |
Guidance vs results
The last range Vertiv gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Adjusted diluted EPS | $1.77 – $1.83 | $2.21 | Above range |
| Q3 FY2026 | EPS (GAAP) | $1.60 | $1.95 | Above range |
| Q3 FY2026 | Revenue | $3.65B – $3.85B | $4.31B | Above range |
| Q2 FY2026 | Adjusted diluted EPS | $1.37 – $1.43 | $1.52 | Above range |
| Q2 FY2026 | EPS (GAAP) | $1.22 | $1.27 | Above range |
| Q2 FY2026 | Revenue | $3.25B – $3.45B | $3.27B | Within range |
| Q1 FY2026 | Adjusted diluted EPS | $0.95 – $1.01 | $1.17 | Above range |
| Q1 FY2026 | EPS (GAAP) | $0.80 | $0.99 | Above range |
| Q1 FY2026 | Revenue | $2.50B – $2.70B | $2.65B | Within range |
| FY2025 | Adjusted diluted EPS | $4.07 – $4.13 | $4.19Σ4Q | Above range |
| FY2025 | EPS (GAAP) | $3.41 | $3.41Σ4Q | Within range |
| FY2025 | Revenue | $10.16B – $10.24B | $10.23BΣ4Q | Within range |
| Q4 FY2025 | Adjusted diluted EPS | $1.23 – $1.29 | $1.36 | Above range |
| Q4 FY2025 | EPS (GAAP) | $1.14 | $1.14 | Within range |
| Q4 FY2025 | Revenue | $2.81B – $2.89B | $2.88B | Within range |
| Q2 FY2025 | Adjusted diluted EPS | $0.77 – $0.85 | $0.95 | Above range |
| Q2 FY2025 | EPS (GAAP) | $0.69 | $0.83 | Above range |
| Q2 FY2025 | Revenue | $2.33B – $2.38B | $2.64B | Above range |
| Q1 FY2025 | Adjusted diluted EPS | $0.57 – $0.63 | $0.64 | Above range |
| Q1 FY2025 | Revenue | $1.90B – $1.95B | $2.04B | Above range |
| Q4 FY2024 | Adjusted diluted EPS | $0.80 – $0.84 | $0.99 | Above range |
| Q4 FY2024 | EPS (GAAP) | $0.61 | $0.38 | Below range |
| Q4 FY2024 | Revenue | $2.12B – $2.17B | $2.35B | Above range |
| Q3 FY2024 | Adjusted diluted EPS | $0.65 – $0.69 | $0.76 | Above range |
| Q3 FY2024 | Revenue | $1.94B – $1.99B | $2.07B | Above range |
| Q2 FY2024 | Adjusted diluted EPS | $0.53 – $0.57 | $0.67 | Above range |
| Q2 FY2024 | Revenue | $1.90B – $1.95B | $1.95B | Above range |
| Q1 FY2024 | Adjusted diluted EPS | $0.32 – $0.36 | $0.43 | Above range |
| Q1 FY2024 | Revenue | $1.58B – $1.63B | $1.64B | Above range |
| Q4 FY2023 | Adjusted diluted EPS | $0.48 – $0.52 | $0.56 | Above range |
| Q4 FY2023 | Revenue | $1.83B – $1.85B | $1.87B | Above range |
| Q3 FY2023 | Adjusted diluted EPS | $0.41 – $0.46 | $0.52 | Above range |
| Q3 FY2023 | Revenue | $1.70B – $1.80B | $1.74B | Within range |
| Q2 FY2023 | Adjusted diluted EPS (1) | $0.25 – $0.31 | $0.46 | Above range |
| Q2 FY2023 | Revenue | $1.55B – $1.65B | $1.73B | Above range |
| Q1 FY2023 | Adjusted diluted EPS | $0.14 – $0.20 | $0.24 | Above range |
| Q1 FY2023 | Revenue | $1.35B – $1.45B | $1.52B | Above range |
| Q4 FY2022 | Adjusted diluted EPS | $0.29 – $0.35 | $0.28 | Below range |
| Q4 FY2022 | Revenue | $1.64B – $1.70B | $1.66B | Within range |
| Q3 FY2022 | Adjusted diluted EPS | $0.20 – $0.26 | $0.23 | Within range |
| Q3 FY2022 | Revenue | $1.46B – $1.50B | $1.48B | Within range |
| Q2 FY2022 | Adjusted diluted EPS | $0.07 – $0.13 | $0.10 | Within range |
| Q2 FY2022 | Revenue | $1.31B – $1.36B | $1.40B | Above range |
| Q1 FY2022 | Adjusted diluted EPS | -$0.20 – -$0.15 | -$0.08 | Above range |
| Q1 FY2022 | Revenue | $1.10B – $1.15B | $1.16B | Above range |
| Q4 FY2021 | Adjusted EPS | $0.24 – $0.30 | $0.04 | Below range |
| Q4 FY2021 | Revenue | $1.38B – $1.44B | $1.41B | Within range |
Guidance history
Every forecast Vertiv put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | Capital expenditures | FY2026 | 4% | New |
| Oct 28, 2026 | Adjusted diluted EPS | Q4 FY2026 | $2.22 – $2.28 | New |
| Oct 28, 2026 | Adjusted diluted EPS | FY2026 | $7.10 – $7.20 | New |
| Oct 28, 2026 | diluted EPS | Q4 FY2026 | $2.08 | New |
| Oct 28, 2026 | diluted EPS | FY2026 | $6.29 | New |
| Oct 28, 2026 | Adjusted free cash flow | FY2026 | $2.60B – $2.80B | New |
| Oct 28, 2026 | Adjusted operating profit | Q4 FY2026 | $1.12B – $1.16B | New |
| Oct 28, 2026 | Adjusted operating profit | FY2026 | $3.48B – $3.56B | New |
| Oct 28, 2026 | Adjusted operating margin | Q4 FY2026 | 25.3% – 26.3% | New |
| Oct 28, 2026 | Adjusted operating margin | FY2026 | 23.5% – 24.5% | New |
| Oct 28, 2026 | Organic net sales growth | Q4 FY2026 | +49% – +51% | New |
| Oct 28, 2026 | Net sales | Q4 FY2026 | $4.31B – $4.51B | New |
| Oct 28, 2026 | Organic net sales growth | FY2026 | +37% – +39% | New |
| Oct 28, 2026 | Net sales | FY2026 | $14.45B – $14.85B | New |
| Jul 29, 2026 | Capital expenditures | FY2026 | 4% | New |
| Jul 29, 2026 | Adjusted diluted EPS | FY2026 | $6.65 – $6.75 | Raised |
| Jul 29, 2026 | Adjusted diluted EPS | Q3 FY2026 | $1.77 – $1.83 | New |
| Jul 29, 2026 | diluted EPS | FY2026 | $5.82 – $5.92 | Raised |
| Jul 29, 2026 | Diluted EPS | Q3 FY2026 | $1.60 | New |
| Jul 29, 2026 | Adjusted free cash flow | FY2026 | $2.40B – $2.60B | Raised |
| Jul 29, 2026 | Adjusted operating profit | FY2026 | $3.29B – $3.37B | Raised |
| Jul 29, 2026 | Adjusted operating profit | Q3 FY2026 | $898.00M – $938.00M | New |
| Jul 29, 2026 | Adjusted operating margin | FY2026 | 23.3% – 24.3% | Raised |
| Jul 29, 2026 | Adjusted operating margin | Q3 FY2026 | 24% – 25% | New |
| Jul 29, 2026 | Adjusted diluted EPS growth | FY2026 | +58% – +61% | Raised |
| Jul 29, 2026 | Adjusted diluted EPS growth | Q3 FY2026 | +43% – +48% | New |
| Jul 29, 2026 | Organic net sales growth | FY2026 | +30% – +32% | Raised |
| Jul 29, 2026 | Net sales | FY2026 | $13.80B – $14.20B | Raised |
| Jul 29, 2026 | Organic net sales growth | Q3 FY2026 | +34% – +36% | New |
| Jul 29, 2026 | Net sales | Q3 FY2026 | $3.65B – $3.85B | New |
| Apr 22, 2026 | Adjusted diluted EPS | FY2026 | $6.30 – $6.40 | Raised |
| Apr 22, 2026 | Adjusted diluted EPS | Q2 FY2026 | $1.37 – $1.43 | New |
| Apr 22, 2026 | diluted EPS | FY2026 | $5.60 – $5.70 | Raised |
| Apr 22, 2026 | Diluted EPS | Q2 FY2026 | $1.22 | New |
| Apr 22, 2026 | Adjusted free cash flow | FY2026 | $2.10B – $2.30B | Reaffirmed |
| Apr 22, 2026 | Adjusted operating profit | FY2026 | $3.14B – $3.26B | Raised |
| Apr 22, 2026 | Adjusted operating profit | Q2 FY2026 | $690.00M – $730.00M | New |
| Apr 22, 2026 | Adjusted operating margin | FY2026 | 22.8% – 23.8% | Raised |
| Apr 22, 2026 | Adjusted operating margin | Q2 FY2026 | 20.7% – 21.7% | New |
| Apr 22, 2026 | Organic net sales growth | FY2026 | +29% – +31% | Lowered |
| Apr 22, 2026 | Adjusted diluted EPS growth | FY2026 | +50% – +52% | Raised |
| Apr 22, 2026 | Organic net sales growth | Q2 FY2026 | +20% – +24% | New |
| Apr 22, 2026 | Adjusted diluted EPS growth | Q2 FY2026 | +44% – +51% | Raised |
| Apr 22, 2026 | Net sales | FY2026 | $13.50B – $14.00B | New |
| Apr 22, 2026 | Net sales | Q2 FY2026 | $3.25B – $3.45B | New |
| Feb 11, 2026 | Adjusted diluted EPS | FY2026 | $5.97 – $6.07 | New |
| Feb 11, 2026 | Adjusted diluted EPS | Q1 FY2026 | $0.95 – $1.01 | New |
| Feb 11, 2026 | diluted EPS | FY2026 | $5.27 – $5.37 | New |
| Feb 11, 2026 | Diluted EPS | Q1 FY2026 | $0.80 | New |
| Feb 11, 2026 | Adjusted free cash flow | FY2026 | $2.10B – $2.30B | New |
| Feb 11, 2026 | Operating profit (loss) | FY2026 | $2.77B | New |
| Feb 11, 2026 | Adjusted operating profit | FY2026 | $2.98B – $3.10B | New |
| Feb 11, 2026 | Operating profit (loss) | Q1 FY2026 | $424.80M | New |
| Feb 11, 2026 | Adjusted operating profit | Q1 FY2026 | $475.00M – $515.00M | New |
| Feb 11, 2026 | Adjusted operating margin | FY2026 | 22% – 23% | New |
| Feb 11, 2026 | Adjusted operating margin | Q1 FY2026 | 18.5% – 19.5% | New |
| Feb 11, 2026 | Adjusted diluted EPS growth | FY2026 | +42% – +45% | New |
| Feb 11, 2026 | Adjusted diluted EPS growth | Q1 FY2026 | +48% – +58% | New |
| Feb 11, 2026 | Organic net sales growth | FY2026 | +27% – +29% | New |
| Feb 11, 2026 | Net sales | FY2026 | $13.25B – $13.75B | New |
| Feb 11, 2026 | Organic net sales growth | Q1 FY2026 | +18% – +26% | New |
| Feb 11, 2026 | Net sales | Q1 FY2026 | $2.50B – $2.70B | New |
| Oct 22, 2025 | capital expenditures | FY2025 | $250.00M | Lowered |
| Oct 22, 2025 | Adjusted diluted EPS | FY2025 | $4.07 – $4.13 | New |
| Oct 22, 2025 | Adjusted diluted EPS | Q4 FY2025 | $1.23 – $1.29 | New |
| Oct 22, 2025 | Diluted EPS | FY2025 | $3.41 | New |
| Oct 22, 2025 | Diluted EPS | Q4 FY2025 | $1.14 | New |
| Oct 22, 2025 | Adjusted free cash flow | FY2025 | $1.47B – $1.53B | New |
| Oct 22, 2025 | Adjusted free cash flow | Q4 FY2025 | $470.00M – $530.00M | New |
| Oct 22, 2025 | Operating profit (loss) | FY2025 | $1.84B | New |
| Oct 22, 2025 | Adjusted operating profit | FY2025 | $2.04B – $2.08B | New |
| Oct 22, 2025 | Operating profit (loss) | Q4 FY2025 | $589.60M | New |
| Oct 22, 2025 | Adjusted operating profit | Q4 FY2025 | $620.00M – $660.00M | New |
| Oct 22, 2025 | Adjusted operating margin | FY2025 | 20% – 20.5% | New |
| Oct 22, 2025 | Adjusted operating margin | Q4 FY2025 | 22.1% – 22.7% | New |
| Oct 22, 2025 | Organic net sales growth | FY2025 | +26% – +28% | New |
| Oct 22, 2025 | Organic net sales growth | Q4 FY2025 | +18% – +22% | New |
| Oct 22, 2025 | Net sales | FY2025 | $10.16B – $10.24B | New |
| Oct 22, 2025 | Net sales | Q4 FY2025 | $2.81B – $2.89B | New |
| Jul 30, 2025 | capital expenditures | FY2025 | $250.00M – $300.00M | New |
| Apr 23, 2025 | capital expenditures | FY2025 | $275.00M | Reaffirmed |
| Apr 23, 2025 | Adjusted diluted EPS | Q2 FY2025 | $0.77 – $0.85 | New |
| Apr 23, 2025 | Adjusted diluted EPS | FY2025 | $3.45 – $3.65 | Reaffirmed |
| Apr 23, 2025 | Diluted EPS | Q2 FY2025 | $0.69 | New |
| Apr 23, 2025 | Diluted EPS | FY2025 | $2.98 | Narrowed |
| Apr 23, 2025 | Adjusted free cash flow | FY2025 | $1.25B – $1.35B | Reaffirmed |
| Apr 23, 2025 | Operating profit (loss) | Q2 FY2025 | $389.00M | New |
| Apr 23, 2025 | Adjusted operating profit | Q2 FY2025 | $420.00M – $450.00M | New |
| Apr 23, 2025 | Operating profit (loss) | FY2025 | $1.75B | Narrowed |
| Apr 23, 2025 | Adjusted operating profit | FY2025 | $1.89B – $1.99B | Reaffirmed |
| Apr 23, 2025 | Adjusted operating margin | Q2 FY2025 | 18% – 19% | New |
| Apr 23, 2025 | Adjusted operating margin | FY2025 | 19.75% – 21.25% | Lowered |
| Apr 23, 2025 | Organic net sales growth | Q2 FY2025 | +19% – +23% | New |
| Apr 23, 2025 | Organic net sales growth | FY2025 | +16.5% – +19.5% | New |
| Apr 23, 2025 | Net sales | Q2 FY2025 | $2.33B – $2.38B | New |
| Apr 23, 2025 | Net sales | FY2025 | $9.33B – $9.58B | Raised |
| Feb 12, 2025 | capital expenditure as % of sales | FY2025 | 3% | New |
| Feb 12, 2025 | capital expenditure | FY2025 | $275.00M | New |
| Feb 12, 2025 | Organic net sales growth | Q1 FY2025 | +17% – +21% | New |
| Feb 12, 2025 | Organic net sales growth | FY2025 | +15% – +17% | New |
| Feb 12, 2025 | Adjusted diluted EPS | Q1 FY2025 | $0.57 – $0.63 | New |
| Feb 12, 2025 | Adjusted diluted EPS | FY2025 | $3.50 – $3.60 | New |
| Feb 12, 2025 | diluted EPS | FY2025 | $2.93 – $3.03 | New |
| Feb 12, 2025 | Adjusted free cash flow | FY2025 | $1.28B – $1.33B | New |
| Feb 12, 2025 | Adjusted operating profit | Q1 FY2025 | $315.00M – $335.00M | New |
| Feb 12, 2025 | operating profit | FY2025 | $1.73B – $1.78B | New |
| Feb 12, 2025 | Adjusted operating profit | FY2025 | $1.91B – $1.96B | New |
| Feb 12, 2025 | Adjusted operating margin | Q1 FY2025 | 16.7% – 17.1% | New |
| Feb 12, 2025 | Adjusted operating margin | FY2025 | 20.8% – 21.2% | New |
| Feb 12, 2025 | Net sales | Q1 FY2025 | $1.90B – $1.95B | New |
| Feb 12, 2025 | Net sales | FY2025 | $9.13B – $9.28B | New |
| Oct 23, 2024 | capital expenditures | FY2024 | $175.00M – $200.00M | New |
| Oct 23, 2024 | Adjusted diluted EPS | Q4 FY2024 | $0.80 – $0.84 | New |
| Oct 23, 2024 | Adjusted diluted EPS | FY2024 | $2.66 – $2.70 | Raised |
| Oct 23, 2024 | Diluted EPS | Q4 FY2024 | $0.61 | New |
| Oct 23, 2024 | Adjusted free cash flow | FY2024 | $975.00M – $1.03B | Raised |
| Oct 23, 2024 | Operating profit (loss) | Q4 FY2024 | $393.00M | New |
| Oct 23, 2024 | Adjusted operating profit | Q4 FY2024 | $427.00M – $447.00M | New |
| Oct 23, 2024 | Adjusted operating profit | FY2024 | $1.48B – $1.50B | Raised |
| Oct 23, 2024 | Adjusted operating margin | Q4 FY2024 | 20.2% – 20.6% | New |
| Oct 23, 2024 | Adjusted operating margin | FY2024 | 18.9% – 19.1% | Raised |
| Oct 23, 2024 | Organic net sales growth | Q4 FY2024 | +11% – +15% | New |
| Oct 23, 2024 | Net sales | Q4 FY2024 | $2.12B – $2.17B | New |
| Oct 23, 2024 | Organic net sales growth | FY2024 | +13% – +15% | Raised |
| Oct 23, 2024 | Net sales | FY2024 | $7.78B – $7.83B | New |
| Jul 24, 2024 | Adjusted diluted EPS | Q3 FY2024 | $0.65 – $0.69 | New |
| Jul 24, 2024 | Adjusted diluted EPS | FY2024 | $2.47 – $2.53 | Raised |
| Jul 24, 2024 | Adjusted free cash flow | FY2024 | $850.00M – $900.00M | Raised |
| Jul 24, 2024 | Adjusted operating profit | Q3 FY2024 | $375.00M – $395.00M | New |
| Jul 24, 2024 | Adjusted operating profit | FY2024 | $1.41B – $1.46B | Raised |
| Jul 24, 2024 | Adjusted operating margin | Q3 FY2024 | 19.4% – 19.8% | New |
| Jul 24, 2024 | Adjusted operating margin | FY2024 | 18.5% – 18.9% | Raised |
| Jul 24, 2024 | Organic net sales growth | Q3 FY2024 | +12% – +16% | New |
| Jul 24, 2024 | Net sales | Q3 FY2024 | $1.94B – $1.99B | New |
| Jul 24, 2024 | Organic net sales growth | FY2024 | +12% – +14% | Raised |
| Jul 24, 2024 | Net sales | FY2024 | $7.59B – $7.74B | Raised |
| Apr 24, 2024 | Adjusted diluted EPS | Q2 FY2024 | $0.53 – $0.57 | New |
| Apr 24, 2024 | Adjusted diluted EPS | FY2024 | $2.29 – $2.35 | Raised |
| Apr 24, 2024 | Adjusted free cash flow | FY2024 | $800.00M – $850.00M | Reaffirmed |
| Apr 24, 2024 | Adjusted operating profit | Q2 FY2024 | $315.00M – $335.00M | New |
| Apr 24, 2024 | operating profit | FY2024 | $1.15B – $1.20B | Raised |
| Apr 24, 2024 | Adjusted operating profit | FY2024 | $1.33B – $1.38B | Raised |
| Apr 24, 2024 | Adjusted operating margin | Q2 FY2024 | 16.7% – 17.1% | New |
| Apr 24, 2024 | Adjusted operating margin | FY2024 | 17.5% – 17.9% | Raised |
| Apr 24, 2024 | Organic net sales growth | Q2 FY2024 | +11% – +13% | New |
| Apr 24, 2024 | Net sales | Q2 FY2024 | $1.90B – $1.95B | New |
| Apr 24, 2024 | Organic net sales growth | FY2024 | +11% – +13% | Raised |
| Apr 24, 2024 | Net sales | FY2024 | $7.54B – $7.69B | Raised |
| Feb 21, 2024 | capital expenditures plan | FY2024 | $175.00M – $200.00M | New |
| Feb 21, 2024 | Adjusted diluted EPS | Q1 FY2024 | $0.32 – $0.36 | New |
| Feb 21, 2024 | Adjusted diluted EPS | FY2024 | $2.20 – $2.26 | New |
| Feb 21, 2024 | Adjusted free cash flow | FY2024 | $800.00M – $850.00M | New |
| Feb 21, 2024 | Adjusted operating profit | Q1 FY2024 | $200.00M – $220.00M | New |
| Feb 21, 2024 | operating profit | FY2024 | $1.10B – $1.15B | New |
| Feb 21, 2024 | Adjusted operating profit | FY2024 | $1.28B – $1.33B | New |
| Feb 21, 2024 | Adjusted operating margin | Q1 FY2024 | 12.9% – 13.3% | New |
| Feb 21, 2024 | Adjusted operating margin | FY2024 | 16.9% – 17.3% | New |
| Feb 21, 2024 | Organic net sales growth | Q1 FY2024 | +3.5% – +6.5% | New |
| Feb 21, 2024 | Net sales | Q1 FY2024 | $1.58B – $1.63B | New |
| Feb 21, 2024 | Organic net sales growth | FY2024 | +9% – +11% | New |
| Feb 21, 2024 | Net sales | FY2024 | $7.52B – $7.66B | New |
| Oct 25, 2023 | Adjusted diluted EPS | Q4 FY2023 | $0.48 – $0.52 | New |
| Oct 25, 2023 | Adjusted diluted EPS | FY2023 | $1.69 – $1.73 | Raised |
| Oct 25, 2023 | Adjusted free cash flow | Q4 FY2023 | $127.00M – $177.00M | New |
| Oct 25, 2023 | Adjusted free cash flow | FY2023 | $600.00M – $650.00M | Raised |
| Oct 25, 2023 | Adjusted operating profit | Q4 FY2023 | $295.00M – $305.00M | New |
| Oct 25, 2023 | operating profit | FY2023 | $842.00M – $852.00M | Raised |
| Oct 25, 2023 | Adjusted operating profit | FY2023 | $1.02B – $1.03B | Raised |
| Oct 25, 2023 | Adjusted operating margin | Q4 FY2023 | 15.9% – 16.7% | New |
| Oct 25, 2023 | Adjusted operating margin | FY2023 | 14.6% – 15.4% | Raised |
| Oct 25, 2023 | Organic net sales growth | Q4 FY2023 | +10.7% – +12.2% | New |
| Oct 25, 2023 | Net sales | Q4 FY2023 | $1.83B – $1.85B | New |
| Oct 25, 2023 | Organic net sales growth | FY2023 | +20.9% – +21.4% | Narrowed |
| Oct 25, 2023 | Net sales | FY2023 | $6.83B – $6.85B | Narrowed |
| Aug 2, 2023 | Adjusted diluted EPS | Q3 FY2023 | $0.41 – $0.46 | New |
| Aug 2, 2023 | Adjusted diluted EPS | FY2023 | $1.54 – $1.64 | Raised |
| Aug 2, 2023 | Adjusted Free Cash Flow | FY2023 | $525.00M – $575.00M | Raised |
| Aug 2, 2023 | Adjusted operating profit | Q3 FY2023 | $245.00M – $260.00M | New |
| Aug 2, 2023 | Adjusted operating profit | FY2023 | $925.00M – $975.00M | Raised |
| Aug 2, 2023 | Adjusted operating margin | Q3 FY2023 | 14.2% – 14.8% | New |
| Aug 2, 2023 | Adjusted operating margin | FY2023 | 13.8% – 14.2% | Raised |
| Aug 2, 2023 | Organic net sales growth | Q3 FY2023 | +15% – +21% | New |
| Aug 2, 2023 | Net sales | Q3 FY2023 | $1.70B – $1.80B | New |
| Aug 2, 2023 | Organic net sales growth | FY2023 | +18% – +22% | Raised |
| Aug 2, 2023 | Net sales | FY2023 | $6.71B – $6.91B | Raised |
| Apr 26, 2023 | Adjusted diluted EPS (1) | Q2 FY2023 | $0.25 – $0.31 | New |
| Apr 26, 2023 | Adjusted diluted EPS (1) | FY2023 | $1.22 – $1.32 | Raised |
| Apr 26, 2023 | Adjusted Free Cash Flow (2) | FY2023 | $300.00M – $400.00M | Reaffirmed |
| Apr 26, 2023 | Adjusted operating profit (1) | Q2 FY2023 | $180.00M – $200.00M | New |
| Apr 26, 2023 | Adjusted operating profit (1) | FY2023 | $775.00M – $825.00M | Raised |
| Apr 26, 2023 | Adjusted operating margin (2) | Q2 FY2023 | 11.6% – 12.1% | New |
| Apr 26, 2023 | Adjusted operating margin (2) | FY2023 | 12% – 12.6% | Raised |
| Apr 26, 2023 | Organic net sales growth (2) | Q2 FY2023 | +12% – +19% | New |
| Apr 26, 2023 | Net sales | Q2 FY2023 | $1.55B – $1.65B | New |
| Apr 26, 2023 | Organic net sales growth (2) | FY2023 | +14% – +16% | Lowered |
| Apr 26, 2023 | Net sales | FY2023 | $6.45B – $6.60B | New |
| Feb 22, 2023 | Adjusted diluted EPS | Q1 FY2023 | $0.14 – $0.20 | New |
| Feb 22, 2023 | Adjusted diluted EPS | FY2023 | $1.17 – $1.27 | New |
| Feb 22, 2023 | Adjusted Free Cash Flow | Q1 FY2023 | -$100.00M – -$50.00M | New |
| Feb 22, 2023 | Adjusted Free Cash Flow | FY2023 | $300.00M – $400.00M | New |
| Feb 22, 2023 | Adjusted operating profit | Q1 FY2023 | $115.00M – $135.00M | New |
| Feb 22, 2023 | operating profit | FY2023 | $568.00M – $618.00M | Raised |
| Feb 22, 2023 | Adjusted operating profit | FY2023 | $750.00M – $800.00M | Raised |
| Feb 22, 2023 | Adjusted operating margin | Q1 FY2023 | 8.5% – 9.3% | New |
| Feb 22, 2023 | Adjusted operating margin | FY2023 | 11.7% – 12.3% | New |
| Feb 22, 2023 | Organic net sales growth | Q1 FY2023 | +21% – +29% | New |
| Feb 22, 2023 | Net sales | Q1 FY2023 | $1.35B – $1.45B | New |
| Feb 22, 2023 | Organic net sales growth | FY2023 | +14% – +17% | New |
| Feb 22, 2023 | Net sales | FY2023 | $6.45B – $6.60B | New |
| Oct 26, 2022 | Adjusted diluted EPS | Q4 FY2022 | $0.29 – $0.35 | Lowered |
| Oct 26, 2022 | Adjusted diluted EPS | FY2022 | $0.53 – $0.59 | Lowered |
| Oct 26, 2022 | free cash flow | Q4 FY2022 | $250.00M – $300.00M | New |
| Oct 26, 2022 | Free Cash Flow | FY2022 | -$150.00M – -$100.00M | Lowered |
| Oct 26, 2022 | operating profit | Q4 FY2022 | $170.00M – $190.00M | New |
| Oct 26, 2022 | adjusted operating profit | Q4 FY2022 | $220.00M – $240.00M | Lowered |
| Oct 26, 2022 | operating profit | FY2022 | $230.00M – $250.00M | Lowered |
| Oct 26, 2022 | Adjusted operating profit | FY2022 | $450.00M – $470.00M | Lowered |
| Oct 26, 2022 | operating profit | FY2023 | $530.00M – $550.00M | New |
| Oct 26, 2022 | adjusted operating profit | FY2023 | $730.00M – $750.00M | New |
| Oct 26, 2022 | Adjusted operating margin | Q4 FY2022 | 13.4% – 14.1% | Lowered |
| Oct 26, 2022 | Adjusted operating margin | FY2022 | 7.9% – 8.2% | Lowered |
| Oct 26, 2022 | Organic net sales growth | Q4 FY2022 | +23% – +28% | Raised |
| Oct 26, 2022 | Net sales | Q4 FY2022 | $1.64B – $1.70B | Lowered |
| Oct 26, 2022 | Organic net sales growth | FY2022 | +13.5% – +14.5% | Raised |
| Oct 26, 2022 | Net sales | FY2022 | $5.68B – $5.74B | Lowered |
| Aug 3, 2022 | Adjusted diluted EPS | Q3 FY2022 | $0.20 – $0.26 | New |
| Aug 3, 2022 | Adjusted diluted EPS | Q4 FY2022 | $0.39 | New |
| Aug 3, 2022 | Adjusted diluted EPS | FY2022 | $0.61 – $0.67 | Lowered |
| Aug 3, 2022 | Free Cash Flow | FY2022 | -$25.00M – $25.00M | Lowered |
| Aug 3, 2022 | Adjusted operating profit | Q3 FY2022 | $130.00M – $150.00M | New |
| Aug 3, 2022 | Adjusted operating profit | Q4 FY2022 | $240.00M – $265.00M | New |
| Aug 3, 2022 | Adjusted operating profit | FY2022 | $475.00M – $500.00M | Lowered |
| Aug 3, 2022 | Adjusted operating margin | Q3 FY2022 | 9.1% – 9.7% | New |
| Aug 3, 2022 | Adjusted operating margin | Q4 FY2022 | 15% | New |
| Aug 3, 2022 | Adjusted operating margin | FY2022 | 8.3% – 8.7% | Lowered |
| Aug 3, 2022 | Organic net sales growth | Q3 FY2022 | +18% – +21% | New |
| Aug 3, 2022 | Net sales | Q3 FY2022 | $1.46B – $1.50B | New |
| Aug 3, 2022 | Organic net sales growth | Q4 FY2022 | +22% – +26% | New |
| Aug 3, 2022 | Net sales | Q4 FY2022 | $1.68B – $1.72B | New |
| Aug 3, 2022 | Organic net sales growth | FY2022 | +13% – +14% | Raised |
| Aug 3, 2022 | Net sales | FY2022 | $5.70B – $5.77B | Narrowed |
| Apr 27, 2022 | Adjusted diluted EPS | Q2 FY2022 | $0.07 – $0.13 | New |
| Apr 27, 2022 | Adjusted diluted EPS | FY2022 | $0.67 – $0.77 | Raised |
| Apr 27, 2022 | Free Cash Flow (2) | FY2022 | $125.00M – $175.00M | Reaffirmed |
| Apr 27, 2022 | Adjusted operating profit | Q2 FY2022 | $70.00M – $90.00M | New |
| Apr 27, 2022 | Adjusted operating profit | FY2022 | $500.00M – $550.00M | Reaffirmed |
| Apr 27, 2022 | Adjusted operating margin (2) | Q2 FY2022 | 5.5% – 6.5% | New |
| Apr 27, 2022 | Adjusted operating margin (2) | FY2022 | 9% – 9.4% | Lowered |
| Apr 27, 2022 | Organic net sales growth (2) | Q2 FY2022 | -2% – +2% | New |
| Apr 27, 2022 | Net sales | Q2 FY2022 | $1.31B – $1.36B | New |
| Apr 27, 2022 | Organic net sales growth (2) | FY2022 | +7% – +11% | New |
| Apr 27, 2022 | Net sales | FY2022 | $5.60B – $5.80B | New |
| Feb 23, 2022 | Adjusted diluted EPS | Q1 FY2022 | -$0.20 – -$0.15 | New |
| Feb 23, 2022 | Adjusted diluted EPS | FY2022 | $0.65 – $0.75 | New |
| Feb 23, 2022 | diluted earnings per share | FY2022 | $0.11 | New |
| Feb 23, 2022 | Free Cash Flow | FY2022 | $125.00M – $175.00M | New |
| Feb 23, 2022 | Adjusted operating profit | Q1 FY2022 | -$30.00M – -$10.00M | New |
| Feb 23, 2022 | Operating profit | FY2022 | $301.00M | New |
| Feb 23, 2022 | Adjusted operating profit | FY2022 | $500.00M – $550.00M | New |
| Feb 23, 2022 | Adjusted operating margin | Q1 FY2022 | -2.8% – -0.8% | New |
| Feb 23, 2022 | Adjusted operating margin | FY2022 | 9.1% – 9.5% | New |
| Feb 23, 2022 | Organic net sales growth | Q1 FY2022 | -4% – +1% | New |
| Feb 23, 2022 | Organic net sales growth | FY2022 | +5% – +11% | New |
| Feb 23, 2022 | Net sales | Q1 FY2022 | $1.10B – $1.15B | New |
| Feb 23, 2022 | Net sales | FY2022 | $5.50B – $5.80B | New |
| Oct 27, 2021 | Adjusted EPS | Q4 FY2021 | $0.24 – $0.30 | New |
| Oct 27, 2021 | Adjusted EPS | FY2021 | $0.97 – $1.03 | New |
| Oct 27, 2021 | Free Cash Flow | FY2021 | $190.00M – $220.00M | New |
| Oct 27, 2021 | Adjusted operating profit | Q4 FY2021 | $166.00M – $186.00M | New |
| Oct 27, 2021 | Adjusted operating profit | FY2021 | $543.00M – $563.00M | New |
| Oct 27, 2021 | Adjusted operating margin | Q4 FY2021 | 12% – 12.9% | New |
| Oct 27, 2021 | Adjusted operating margin | FY2021 | 10.9% – 11.2% | New |
| Oct 27, 2021 | Organic net sales growth | Q4 FY2021 | +3% – +7% | New |
| Oct 27, 2021 | Net sales | Q4 FY2021 | $1.38B – $1.44B | New |
| Oct 27, 2021 | Organic net sales growth | FY2021 | +10.5% – +11.5% | New |
| Oct 27, 2021 | Net sales | FY2021 | $4.97B – $5.03B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Vertiv filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Update
- News
- Results
- Update
- News
- Update
- Results
- Update
- Update
- News
- Update